Insider Selling: Agilent Technologies, Inc. (NYSE:A) VP Sells 5,879 Shares of Stock

Agilent Technologies, Inc. (NYSE:AGet Rating) VP Jacob Thaysen sold 5,879 shares of Agilent Technologies stock in a transaction that occurred on Thursday, June 2nd. The stock was sold at an average price of $127.43, for a total transaction of $749,160.97. Following the transaction, the vice president now directly owns 88,737 shares in the company, valued at approximately $11,307,755.91. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Shares of NYSE:A traded down $1.27 during midday trading on Monday, reaching $127.22. 27,269 shares of the company’s stock traded hands, compared to its average volume of 2,104,293. The company has a market cap of $38.00 billion, a price-to-earnings ratio of 30.96, a P/E/G ratio of 2.62 and a beta of 1.05. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.49 and a current ratio of 2.01. Agilent Technologies, Inc. has a one year low of $112.64 and a one year high of $179.57. The stock has a 50 day moving average of $125.50 and a 200 day moving average of $137.23.

Agilent Technologies (NYSE:AGet Rating) last issued its quarterly earnings results on Tuesday, May 24th. The medical research company reported $1.13 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.01. The business had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.62 billion. Agilent Technologies had a return on equity of 27.42% and a net margin of 19.35%. The business’s quarterly revenue was up 5.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.97 earnings per share. Sell-side analysts predict that Agilent Technologies, Inc. will post 4.9 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 27th. Shareholders of record on Tuesday, July 5th will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Friday, July 1st. Agilent Technologies’s dividend payout ratio (DPR) is 20.24%.

Several equities analysts have commented on A shares. SVB Leerink decreased their price objective on shares of Agilent Technologies from $175.00 to $145.00 and set an “outperform” rating on the stock in a report on Wednesday, February 23rd. Citigroup dropped their target price on shares of Agilent Technologies from $190.00 to $175.00 and set a “buy” rating for the company in a report on Wednesday, February 23rd. Bank of America lowered their price objective on Agilent Technologies from $179.00 to $160.00 and set a “buy” rating for the company in a research note on Wednesday, February 23rd. Robert W. Baird raised their price objective on shares of Agilent Technologies from $155.00 to $161.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 25th. Finally, StockNews.com raised shares of Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Agilent Technologies presently has an average rating of “Buy” and an average price target of $160.58.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Twinbeech Capital LP purchased a new stake in shares of Agilent Technologies during the third quarter valued at about $11,847,000. Eversept Partners LP increased its holdings in Agilent Technologies by 4.1% in the 4th quarter. Eversept Partners LP now owns 19,431 shares of the medical research company’s stock worth $3,102,000 after buying an additional 771 shares during the period. M&T Bank Corp increased its holdings in Agilent Technologies by 6.4% in the 4th quarter. M&T Bank Corp now owns 51,649 shares of the medical research company’s stock worth $8,246,000 after buying an additional 3,108 shares during the period. Strs Ohio increased its holdings in Agilent Technologies by 14.7% in the 4th quarter. Strs Ohio now owns 28,306 shares of the medical research company’s stock worth $4,519,000 after buying an additional 3,617 shares during the period. Finally, Astrantus Ltd acquired a new position in Agilent Technologies in the 4th quarter worth approximately $303,000.

About Agilent Technologies (Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Further Reading

Insider Buying and Selling by Quarter for Agilent Technologies (NYSE:A)

Want More Great Investing Ideas?

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.